|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 |
| (11) | Number of the document | 2729172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12748078.8 |
| Date of filing the European patent application | 2012-07-02 | |
| (97) | Date of publication of the European application | 2014-05-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/045235 |
| Date | 2012-07-02 |
| (87) | Number | WO 2013/006547 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201161504633 P | 2011-07-05 | US | |
| 201161558945 P | 2011-11-11 | US |
| (72) |
BUKHALID, Raghida, US
FELDHAUS, Michael, US
KING, Anne, US
KOHLI, Neeraj, US
KRAULAND, Eric, US
KEARNS, Jeffrey, David, US
LUGOVSKOY, Alexey, A., US
NIELSEN, Ulrik, US
|
| (73) |
Merrimack Pharmaceuticals, Inc.,
One Kendall Square Suite B7201, Cambridge, MA 02139,
US
|
| (54) | ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF |
| ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF |